VW5.F The Cannabist Company Holdings Inc.
- Market cap
- EUR 10.1M
- P/E
- -
- P/B
- 4.67x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2025.
Is VW5.F undervalued?
Graham numberThe Graham number of The Cannabist Company Holdings Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
The Cannabist Company Holdings Inc. fundamental analysis
No fundamental analysis for The Cannabist Company Holdings Inc. yet.
The Cannabist Company Holdings Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About The Cannabist Company Holdings Inc.
The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally. The company operates medical and/or adult use marijuana businesses and dispensaries. It also offers flowers, concentrates, edibles, oils and tablets, and accessories under the dreamt, Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brands. In addition, the company pro…
Full company profileThe Cannabist Company Holdings Inc. financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
The Cannabist Company Holdings Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 460M | 512M | 511M | 459M | 338M |
| Gross Profit | 194M | 201M | 180M | 168M | 92.5M |
| Operating Income | -38.0M | -76.1M | -19.6M | -20.1M | -47.8M |
| EBITDA | -63.7M | 8.67M | 43.1M | 28.9M | -25.8M |
| Net Income | -143M | -416M | -176M | -106M | -166M |
| EPS | -0.38 | -1.04 | -0.41 | -0.22 | -0.33 |
| Balance Sheet | |||||
| Total Assets | 1.38B | 995M | 823M | 696M | 537M |
| Total Liabilities | 826M | 788M | 758M | 726M | 689M |
| Shareholders' Equity | 571M | 213M | 66.9M | -28.7M | -152M |
| Cash & Short-term Investments | 82.2M | 48.2M | 35.8M | 33.6M | 17.8M |
| Cash Flow | |||||
| Operating Cash Flow | -523K | -111M | 7.47M | -23.4M | -47.6M |
| Capital Expenditure | 118M | 72.7M | 9.97M | 5.83M | 5.47M |
| Free Cash Flow | -118M | -184M | -2.50M | -29.2M | -53.0M |
| Ratios | |||||
| ROE | -25.0% | -195.0% | -262.8% | - | - |
| ROA | -10.4% | -41.8% | -21.3% | -15.2% | -30.9% |
| Net Profit Margin | -31.1% | -81.3% | -34.4% | -23.1% | -49.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
The Cannabist Company Holdings Inc. dividends
The Cannabist Company Holdings Inc. has not paid dividends in the last 4 fiscal years.
Who owns The Cannabist Company Holdings Inc.
- Insiders 4.88%
- Institutions 13.50%
- Public & others 81.62%
- Shares outstanding 490M
- Free float 486M
The Cannabist Company Holdings Inc. company profile
- Company name
- The Cannabist Company Holdings Inc.
- Ticker
- VW5.F
- ISIN
- CA13765Y1034
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 1,681
- Fiscal year end
- December
- Address
- 321 Billerica Rd., Chelmsford, MA, United States, 01824
- Phone
- 978 910 1486
- Website
- cannabistcompany.com
About The Cannabist Company Holdings Inc.
The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally. The company operates medical and/or adult use marijuana businesses and dispensaries. It also offers flowers, concentrates, edibles, oils and tablets, and accessories under the dreamt, Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brands. In addition, the company provides management services to licensed entities. The company was formerly known as Columbia Care Inc. and changed its name to The Cannabist Company Holdings Inc. in September 2023. The Cannabist Company Holdings Inc. was founded in 2012 and is headquartered in Chelmsford, Massachusetts.
The Cannabist Company Holdings Inc. management
5- Mr. David J. HartCEO & Director · born 1977
- Mr. Derek WatsonChief Financial Officer · born 1971
- Mr. David SirollyChief Legal Officer & General Counsel · born 1975
- Mr. Bryan Lamont OlsonChief Human Resources Officer · born 1974
- Ms. Lee Ann EvansSenior Vice President of Capital Markets